RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
23 Agosto 2023 - 5:05PM
RxSight, Inc., an ophthalmic medical device company dedicated to
providing high-quality customized vision to patients following
cataract surgery, today announced plans to participate in the
upcoming Wells Fargo Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside
chat on Wednesday, September 6, 2023, at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation at:
https://investors.rxsight.com/news-events/investor-calendar.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that can be adjusted after
surgery enabling doctors to customize and deliver high-quality of
vision to patients after cataract surgery. Additional information
about RxSight can be found at www.rxsight.com.
Company Contact:Shelley ThunenRxSight,
Inc.sthunen@rxsight.com
Investor Relations Contact:ir@rxsight.com
RxSight (NASDAQ:RXST)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
RxSight (NASDAQ:RXST)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024